Stock 8403 SHAREHOPE MEDICINE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials ShareHope Medicine Co., Ltd.

Equities

8403

TW0008403007

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
31.4 TWD -0.48% Intraday chart for ShareHope Medicine Co., Ltd. +0.16% -4.56%
Mar. 20 ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,514 3,064 3,788 3,087 4,057 4,147
Enterprise Value (EV) 1 2,262 2,679 2,943 2,723 4,518 4,933
P/E ratio 16.9 x 16.2 x 15.7 x 13.4 x 13.9 x 33.6 x
Yield 1.94% - 1.43% 1.85% 1.48% -
Capitalization / Revenue 0.82 x 0.98 x 0.92 x 0.8 x 0.98 x 1.07 x
EV / Revenue 0.74 x 0.86 x 0.72 x 0.71 x 1.09 x 1.27 x
EV / EBITDA 11.4 x 9.87 x 4.49 x 6.26 x 9.04 x 17.9 x
EV / FCF -12.4 x 5.88 x 16 x 29.9 x -7.26 x -46.2 x
FCF Yield -8.07% 17% 6.24% 3.35% -13.8% -2.17%
Price to Book 1.07 x 1.22 x 1.3 x 0.98 x 1.19 x 1.19 x
Nbr of stocks (in thousands) 124,285 124,285 125,649 126,044 126,044 126,044
Reference price 2 20.23 24.65 30.15 24.49 32.19 32.90
Announcement Date 3/28/19 3/31/20 3/31/21 3/31/22 3/31/23 3/20/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,057 3,124 4,099 3,850 4,137 3,873
EBITDA 1 198.3 271.5 654.9 435 499.5 276.1
EBIT 1 66.16 139 513.7 254.3 329.4 94.69
Operating Margin 2.16% 4.45% 12.53% 6.6% 7.96% 2.44%
Earnings before Tax (EBT) 1 165.2 204.3 479.1 267.6 339.9 109
Net income 1 145.9 195.1 247.7 232.7 293.9 124.6
Net margin 4.77% 6.24% 6.04% 6.04% 7.11% 3.22%
EPS 2 1.198 1.519 1.919 1.830 2.314 0.9800
Free Cash Flow 1 -182.5 456 183.7 91.18 -622.2 -106.8
FCF margin -5.97% 14.6% 4.48% 2.37% -15.04% -2.76%
FCF Conversion (EBITDA) - 167.95% 28.06% 20.96% - -
FCF Conversion (Net income) - 233.78% 74.18% 39.19% - -
Dividend per Share 2 0.3920 - 0.4319 0.4535 0.4762 -
Announcement Date 3/28/19 3/31/20 3/31/21 3/31/22 3/31/23 3/20/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 460 787
Net Cash position 1 251 385 845 364 - -
Leverage (Debt/EBITDA) - - - - 0.9211 x 2.848 x
Free Cash Flow 1 -183 456 184 91.2 -622 -107
ROE (net income / shareholders' equity) 5.8% 6.81% 11.5% 5.18% 6.12% 1.37%
ROA (Net income/ Total Assets) 1.15% 2.15% 6.54% 2.69% 3.05% 0.8%
Assets 1 12,717 9,053 3,785 8,637 9,632 15,601
Book Value Per Share 2 19.00 20.20 23.20 25.00 27.10 27.70
Cash Flow per Share 2 5.590 8.400 13.40 12.40 12.20 11.00
Capex 1 102 104 358 138 1,266 250
Capex / Sales 3.35% 3.33% 8.73% 3.57% 30.6% 6.46%
Announcement Date 3/28/19 3/31/20 3/31/21 3/31/22 3/31/23 3/20/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SHAREHOPE MEDICINE CO., LTD. Stock ShareHope Medicine Co., Ltd.
-4.56% 121M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-3.38% 3.93B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 8403 Stock
  4. Financials ShareHope Medicine Co., Ltd.